Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation Behavior
ACS Applied Bio Materials · 19.01.2026 · 9 (2) · 992-1007
DOI: 10.1021/acsabm.5c01880 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 25.12.2025. Verfasst von Maolin Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China. Hauptthemen laut MEDLINE: Nanoparticles, Polylactic Acid-Polyglycolic Acid Copolymer, Eicosapentaenoic Acid, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Australian Research Council, Fundamental Research Funds for the Central Universities, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
A persistent challenge in the use of biodegradable implants is the lack of precise spatiotemporal control over immune modulation at the implant site. This is particularly critical for materials, such as magnesium alloys, which generate a locally alkaline environment upon degradation. Here, we report a pH-responsive nanoparticle system composed of poly(lactide-co-glycolide) and Eudragit S100 (PLGA-ES100 NPs), engineered to degrade under alkaline conditions and enable on-demand release of the pro-resolving mediator Resolvin E1 (RvE1). The nanoparticles promote macrophage migration and polarization toward an anti-inflammatory M2 phenotype only under alkaline conditions, with TNF-α and IL-1β expression markedly suppressed following RvE1 release. When implanted subcutaneously with AZ31 magnesium alloys in rats, RvE1-loaded nanoparticles resulted in the thinnest fibrotic capsule (52.15 μm) and highest CD163 expression, confirming effective in vivo immunomodulation. In contrast, barrier coatings that restricted RvE1 release abrogated this response. This study establishes a strategy for leveraging implant-driven pH changes to trigger localized, inflammation-resolving drug release. The PLGA-ES100-RvE1 system offers a modular platform for controlling immune responses at bioresorbable implant interfaces.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
- Key Laboratory of Advanced Technologies of Materials Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
- School of Biomedical Engineering, University of Sydney, Sydney 2006, New South Wales, Australia.
- School of Engineering, Hunter Medical Research Institute, University of Newcastle, Newcastle 2261, New South Wales, Australia.
ORCID-Profile: Maolin Sun, Behnam Akhavan
Förderung
- Australian Research Council
- Fundamental Research Funds for the Central Universities
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Sun, M., Han, Y., Mamizadehjanghour, L., Han, Y., Zhao, A., Akhavan, B., & Qian, L. (2026). Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation Behavior. ACS Applied Bio Materials, 9(2), 992-1007. https://doi.org/10.1021/acsabm.5c01880
Vancouver
Sun M, Han Y, Mamizadehjanghour L, Han Y, Zhao A, Akhavan B, et al. Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation Behavior. ACS Applied Bio Materials. 2026;9(2):992-1007. doi:10.1021/acsabm.5c01880
BibTeX
@article{Sun2026,
author = {Sun, Maolin and Han, Yi and Mamizadehjanghour, Leila and Han, Yuning and Zhao, Ansha and Akhavan, Behnam and Qian, Liubin},
title = {Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation Behavior},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {2},
pages = {992--1007},
doi = {10.1021/acsabm.5c01880}
}
EUVIMED